NASDAQ : SCYX

SCYNEXIS, Inc. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 3.76 USD (Oct 30, 2026, 1:55 PM EDT) · Market cap 37.41M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

SCYNEXIS, Inc. (SCYX) reported revenue of 19.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue19.22M20.60M3.75M140.14M5.09M13.16M
Cost of Revenue15.62M628.00K312.00K
Gross Profit19.22M20.60M3.75M124.52M4.46M12.85M
Selling, General & Admin15.57M14.39M14.46M20.92M62.96M49.92M
Research & Development26.24M22.28M26.41M30.93M27.26M23.77M
Operating Expenses41.81M36.67M40.86M51.85M90.22M73.69M
Operating Income-22.60M-16.07M-37.12M72.67M-85.76M-60.84M
Interest Expense-485.00K-2.55M-6.12M-6.79M-3.96M
Interest & Investment Income2.04M2.18M4.29M3.95M1.42M24.00K
Other Non Operating Income (Expenses)10.32M5.77M14.24M-3.32M23.62M31.55M
EBT Excluding Unusual Items-10.23M-8.61M-21.14M67.18M-67.51M-33.23M
Other Unusual Items-2.73M
Pretax Income-10.23M-8.61M-21.14M67.18M-67.51M-35.95M
Income Tax Expense151.00K138.00K-4.70M-3.09M
Earnings From Continuing Operations-10.23M-8.61M-21.29M67.04M-62.81M-32.87M
Net Income-10.23M-8.61M-21.29M67.04M-62.81M-32.87M
Net Income to Common-10.23M-8.61M-21.29M67.04M-62.81M-32.87M
Shares Outstanding (Basic)7.70M6.24M6.06M5.98M5.33M3.30M
Shares Outstanding (Diluted)7.70M6.24M6.06M6.05M5.33M3.30M
EPS (Basic)-1.33-1.38-3.5111.21-11.79-9.97
EPS (Diluted)-1.33-1.38-3.5111.12-11.79-10.00
Free Cash Flow-13.31M-5.28M-24.01M60.16M-79.88M-54.56M
Free Cash Flow Per Share-1.73-0.85-3.969.95-15.00-16.54
Gross Margin100.00%100.00%100.00%88.85%87.67%97.63%
Operating Margin-117.61%-78.03%-990.84%51.85%-1,684.48%-462.19%
Profit Margin-53.26%-41.79%-568.29%47.84%-1,233.73%-249.68%
Free Cash Flow Margin-69.26%-25.64%-640.92%42.93%-1,569.10%-414.49%
EBITDA-36.54M73.25M-85.15M-60.46M
EBITDA Margin52.27%
D&A For EBITDA580.00K580.00K606.00K379.00K
EBIT-22.60M-16.07M-37.12M72.67M-85.76M-60.84M
EBIT Margin-117.61%-78.03%51.85%
Effective Tax Rate0.21%
Revenue as Reported20.60M20.60M3.75M140.14M5.09M13.16M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents10.49M21.26M16.05M34.05M45.81M104.48M
Short-Term Investments43.60M18.77M43.25M40.31M27.69M
Cash & Short-Term Investments54.08M40.03M59.30M74.36M73.50M104.48M
Accounts Receivable10.26M21.83M2.10M861.00K
Receivables10.26M21.83M2.10M861.00K
Inventory899.00K463.00K
Prepaid Expenses610.00K246.00K950.00K642.00K2.44M3.56M
Restricted Cash80.00K80.00K435.00K380.00K55.00K
Other Current Assets1.46M17.00K1.23M4.91M62.00K4.00K
Total Current Assets56.24M40.37M72.18M102.12M79.06M109.38M
Property, Plant & Equipment1.58M1.76M2.09M2.36M2.59M2.80M
Long-Term Investments17.05M16.25M15.85M23.59M
Other Intangible Assets408.00K1.06M
Long-Term Deferred Charges533.00K417.00K175.00K73.00K150.00K
Other Long-Term Assets109.00K109.00K109.00K163.00K5.67M6.45M
Total Assets74.97M59.03M90.64M128.41M87.81M119.84M
Accounts Payable3.27M2.23M4.57M7.15M5.94M7.85M
Accrued Expenses2.03M2.79M3.79M7.50M5.63M5.70M
Current Portion of Long-Term Debt13.69M
Current Portion of Leases526.00K483.00K407.00K340.00K282.00K70.00K
Current Unearned Revenue235.00K1.64M1.19M
Other Current Liabilities130.00K5.77M
Total Current Liabilities5.83M5.73M24.10M16.30M17.62M13.62M
Long-Term Debt11.96M45.35M38.99M
Long-Term Leases1.42M1.69M2.17M2.58M2.92M3.20M
Long-Term Unearned Revenue1.29M2.73M
Other Long-Term Liabilities796.00K2.23M8.00M21.88M18.69M22.77M
Total Liabilities8.04M9.65M35.57M55.45M84.58M78.58M
Common Stock10.00K46.00K41.00K40.00K36.00K32.00K
Additional Paid-In Capital465.97M434.47M431.57M428.17M425.49M400.70M
Retained Earnings-399.05M-385.14M-376.54M-355.25M-422.29M-359.48M
Shareholders' Equity66.93M49.38M55.08M72.96M3.23M41.26M
Total Liabilities & Equity74.97M59.03M90.64M128.41M87.81M119.84M
Total Debt1.95M2.17M16.27M14.88M48.55M42.27M
Net Cash (Debt)52.14M37.86M43.03M59.48M24.95M62.22M
Net Cash Per Share6.776.077.109.834.6818.86
Filing Date Shares Outstanding9.95M5.58M4.87M4.72M4.17M3.62M
Total Common Shares Outstanding9.95M5.44M4.75M4.65M4.09M3.59M
Working Capital50.41M34.64M48.08M85.81M61.44M95.76M
Book Value Per Share6.739.0711.6015.690.7911.50
Tangible Book Value66.93M49.38M55.08M72.96M2.83M40.20M
Tangible Book Value Per Share6.739.0711.6015.690.6911.20

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-10.23M-8.61M-21.29M67.04M-62.81M-32.87M
Depreciation & Amortization580.00K606.00K379.00K
Other Amortization312.00K1.73M3.51M1.59M1.30M
Loss (Gain) From Sale of Investments-268.00K-474.00K-1.34M-1.34M-309.00K
Stock-Based Compensation2.36M2.85M3.35M2.62M3.69M2.09M
Other Operating Activities-8.34M-5.45M-13.74M18.39M-23.41M-28.61M
Change in Accounts Receivable10.00M10.26M11.56M-19.73M-1.24M-861.00K
Change in Inventory-8.85M-436.00K-5.29M
Change in Accounts Payable-3.51M-2.23M-2.65M1.17M-1.48M2.76M
Change in Unearned Revenue-2.29M-2.70M-979.00K3.92M
Change in Other Net Operating Assets-1.03M757.00K-652.00K-7.16M3.92M6.54M
Operating Cash Flow-13.31M-5.28M-24.01M60.16M-79.88M-54.56M
Sale (Purchase) of Intangibles-9.00K-1.17M
Investment in Securities-24.69M24.31M6.15M-34.88M-27.38M
Investing Cash Flow-24.69M24.31M6.15M-34.88M-27.39M-1.17M
Long-Term Debt Issued5.00M30.00M
Long-Term Debt Repaid-14.00M-36.38M
Net Debt Issued (Repaid)-14.00M-36.38M5.00M30.00M
Issuance of Common Stock40.07M56.00K56.00K42.00K47.27M38.57M
Other Financing Activities-2.65M-226.00K-195.00K-380.00K-3.66M-1.45M
Financing Cash Flow37.41M-14.17M-139.00K-36.72M48.60M67.12M
Net Cash Flow-588.00K4.85M-18.00M-11.44M-58.67M11.39M
Free Cash Flow-13.31M-5.28M-24.01M60.16M-79.88M-54.56M
Free Cash Flow Margin-69.26%-25.64%-640.92%42.93%-1,569.10%-414.49%
Free Cash Flow Per Share-1.73-0.85-3.969.95-15.00-16.54
Levered Free Cash Flow-7.32M599.62K-10.81M24.73M-48.84M-50.43M
Unlevered Free Cash Flow-7.32M590.75K-10.94M25.57M-46.19M-49.25M
Cash Interest Paid420.00K840.00K3.25M5.19M2.25M
Change in Working Capital3.17M6.08M7.28M-30.64M764.00K3.15M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization37.91M26.54M45.92M82.97M50.94M173.97M
Enterprise Value-14.23M-9.11M-7.01M9.48M3.08M115.82M
Last Close Price3.815.069.6817.8412.4848.80
PE Ratio1.24
Forward PE1.7132.4934.20
PS Ratio1.971.2912.260.5910.0113.22
PB Ratio0.570.540.831.1415.764.22
P/TBV Ratio0.570.540.831.1418.034.33
P/FCF Ratio1.38
P/OCF Ratio1.38
PEG Ratio1.971.977.77
EV/Sales Ratio0.070.608.80
EV/EBITDA Ratio0.13
EV/EBIT Ratio0.13
EV/FCF Ratio0.16
Debt / Equity Ratio0.030.040.290.2015.021.02
Debt / EBITDA Ratio0.20
Debt / FCF Ratio0.25
Net Debt / Equity Ratio-0.78-0.77-0.78-0.81-7.72-1.51
Net Debt / EBITDA Ratio1.18-0.810.291.03
Net Debt / FCF Ratio3.927.171.79-0.990.311.14
Asset Turnover0.280.280.031.300.050.12
Inventory Turnover0.92
Quick Ratio9.296.982.895.904.297.74
Current Ratio9.657.043.006.264.498.03
Return on Equity (ROE)-18.38%-16.48%-33.25%175.97%-282.34%-102.68%
Return on Assets (ROA)-20.82%-13.42%-21.18%42.01%-51.62%-34.20%
Return on Invested Capital (ROIC)-152.78%-136.41%-290.76%537.82%
Return on Capital Employed (ROCE)-32.70%-30.20%-55.80%64.80%-122.20%-57.30%
Earnings Yield-34.89%-32.44%-46.36%80.80%-123.29%-18.89%
FCF Yield-35.11%-19.91%-52.29%72.50%-156.80%-31.36%
Buyback Yield / Dilution-25.40%-2.93%-0.25%-13.56%-61.51%-146.12%